Chugai Pharmaceutical Co (CUP) Stock Forecast & Price Target
CUP Analyst Ratings
Moderate Buy
6Buy5Hold0Sell
Based on 11 analysts giving stock ratings to Chugai Pharmaceutical Co in the past 3 months
CUP Stock 12 Month Forecast
Average Price Target
EUR 45.89▲(19.48% Upside)Based on 11 Wall Street analysts offering 12 month price targets for Chugai Pharmaceutical Co in the last 3 months. The average price target is EUR 45.89 with a high forecast of EUR 62.54 and a low forecast of EUR 34.68. The average price target represents a 19.48% change from the last price of EUR 38.41.
Past 12 Months12 Month ForecastDec2025Sep2026
HighEUR 62.54
AverageEUR 45.89
LowEUR 34.68
Highest Price TargetHighestEUR 62.54Average Price TargetEUR 45.89Lowest Price TargetLowestEUR 34.68
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Analyst Profile | Expert Firm | Price Target | Position | Upside / Downside | Action | Date | Follow | Article |
|---|---|---|---|---|---|---|---|---|
 Unknown AnalystNot Ranked | Citi | EUR 63.10→EUR 62.54 | buy | 62.81%Upside | Reiterated | 10/29/26 | ||
| Unknown AnalystNot Ranked | Morgan Stanley | EUR 47.47 | buy | 23.59%Upside | Reiterated | 10/28/26 | ||
| Asad Haider | Goldman Sachs | EUR 49.74 | buy | 29.51%Upside | Reiterated | 10/20/26 | ||
| Unknown AnalystNot Ranked | Macquarie | EUR 43.21→EUR 41.50 | buy | 8.05%Upside | Reiterated | 10/16/26 | ||
| Unknown AnalystNot Ranked | UBS | EUR 40.93→EUR 38.09 | hold | -0.83%Downside | Reiterated | 10/14/26 | ||
| Stephen Barker | Jefferies | EUR 45.48→EUR 34.68 | hold | -9.71%Downside | Reiterated | 09/29/26 | ||
| Unknown AnalystNot Ranked | Daiwa | EUR 50.60 | buy | 31.73%Upside | Reiterated | 09/28/26 | ||
| Unknown AnalystNot Ranked | SBI Securities | EUR 54.01 | buy | 40.61%Upside | Reiterated | 09/09/26 | ||
| Unknown AnalystNot Ranked | Nomura | EUR 45.48→EUR 43.21 | hold | 12.49%Upside | Reiterated | 09/01/26 | ||
| Unknown AnalystNot Ranked | Mizuho Securities | EUR 46.90→EUR 40.36 | hold | 5.09%Upside | Reiterated | 08/19/26 | ||
| Unknown AnalystNot Ranked | Bank of America Securities | EUR 50.03→EUR 42.64 | hold | 11.01%Upside | Reiterated | 08/14/26 | ||
| Miki Sogi | Bernstein | EUR 55.71 | buy | 45.05%Upside | Reiterated | 07/07/26 | ||
| Unknown AnalystNot Ranked | J.P. Morgan | EUR 62.54 | buy | 62.81%Upside | Reiterated | 05/27/26 | ||
| Unknown AnalystNot Ranked | SMBC Nikko | EUR 54.01→EUR 60.83 | buy | 58.37%Upside | Reiterated | 02/25/26 |
| Analyst Profile | Date | Price Target | Position | Upside / Downside | Action | Follow | Article | Expert Firm |
|---|---|---|---|---|---|---|---|---|
| Unknown AnalystNot Ranked | 10/29/26 | EUR 63.10→EUR 62.54 | buy | 62.81%Upside | Reiterated | Citi | ||
| Unknown AnalystNot Ranked | 10/28/26 | EUR 47.47 | buy | 23.59%Upside | Reiterated | Morgan Stanley | ||
| Asad Haider | 10/20/26 | EUR 49.74 | buy | 29.51%Upside | Reiterated | Goldman Sachs | ||
| Unknown AnalystNot Ranked | 10/16/26 | EUR 43.21→EUR 41.50 | buy | 8.05%Upside | Reiterated | Macquarie | ||
| Unknown AnalystNot Ranked | 10/14/26 | EUR 40.93→EUR 38.09 | hold | -0.83%Downside | Reiterated | UBS | ||
| Stephen Barker | 09/29/26 | EUR 45.48→EUR 34.68 | hold | -9.71%Downside | Reiterated | Jefferies | ||
| Unknown AnalystNot Ranked | 09/28/26 | EUR 50.60 | buy | 31.73%Upside | Reiterated | Daiwa | ||
| Unknown AnalystNot Ranked | 09/09/26 | EUR 54.01 | buy | 40.61%Upside | Reiterated | SBI Securities | ||
| Unknown AnalystNot Ranked | 09/01/26 | EUR 45.48→EUR 43.21 | hold | 12.49%Upside | Reiterated | Nomura | ||
| Unknown AnalystNot Ranked | 08/19/26 | EUR 46.90→EUR 40.36 | hold | 5.09%Upside | Reiterated | Mizuho Securities | ||
| Unknown AnalystNot Ranked | 08/14/26 | EUR 50.03→EUR 42.64 | hold | 11.01%Upside | Reiterated | Bank of America Securities | ||
| Miki Sogi | 07/07/26 | EUR 55.71 | buy | 45.05%Upside | Reiterated | Bernstein | ||
| Unknown AnalystNot Ranked | 05/27/26 | EUR 62.54 | buy | 62.81%Upside | Reiterated | J.P. Morgan | ||
| Unknown AnalystNot Ranked | 02/25/26 | EUR 54.01→EUR 60.83 | buy | 58.37%Upside | Reiterated | SMBC Nikko |
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Best Analysts Covering Chugai Pharmaceutical Co
3 Months
Success Rate4/6 ratings generated profit
67%
Average Return
+9.65%
Copying Seiji Wakao's trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +9.65% per trade.
1 Year
Success Rate3/5 ratings generated profit
60%
Average Return
-5.50%
Copying Tony Ren's trades and holding each position for 1 Year would result in 60.00% of your transactions generating a profit, with an average return of -5.50% per trade.
2 Years
Success Rate1/6 ratings generated profit
17%
Average Return
-8.28%
Copying Seiji Wakao's trades and holding each position for 2 Years would result in 16.67% of your transactions generating a profit, with an average return of -8.28% per trade.
CUP Analyst Recommendation Trends
| Rating | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 2 |
| Buy | 4 | 6 | 5 | 7 | 6 |
| Hold | 9 | 5 | 5 | 6 | 6 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 14 | 12 | 11 | 14 | 14 |
In the current month, CUP has received 8 Buy Ratings, 6 Hold Ratings, and 0 Sell Ratings. CUP average Analyst price target in the past 3 months is 45.89.
CUP Financial Forecast
HighEUR 0.48
ConsensusEUR 0.44
LowEUR 0.39
CUP Earnings Forecast
Next quarter’s earnings estimate for CUP is EUR 0.44 with a range of EUR 0.39 to EUR 0.48. The previous quarter’s EPS was EUR 0.53. CUP beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year CUP has Performed in-line its overall industry.
HighEUR 2.15B
ConsensusEUR 1.94B
LowEUR 1.64B
CUP Sales Forecast
Next quarter’s sales forecast for CUP is EUR 1.94B with a range of EUR 1.64B to EUR 2.15B. The previous quarter’s sales results were EUR 2.30B. CUP beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year CUP has Performed in-line its overall industry.
CUP Stock Forecast FAQ
What is DE:CUP’s average 12-month price target, according to analysts?
Based on analyst ratings, Chugai Pharmaceutical Co’s 12-month average price target is €45.89.
What is DE:CUP’s upside potential, based on the analysts’ average price target?
Chugai Pharmaceutical Co has 19.48% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Chugai Pharmaceutical Co a Buy, Sell or Hold?
Chugai Pharmaceutical Co has a consensus rating of Moderate Buy, which is based on 6 buy ratings, 5 hold ratings and 0 sell ratings.
What is Chugai Pharmaceutical Co’s share price target?
The average share price target for Chugai Pharmaceutical Co is €45.89. This is based on 11 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is €62.54, and the lowest forecast is €34.68. The average share price target represents a 19.48% increase from the current price of €38.41.
What do analysts say about Chugai Pharmaceutical Co?
Chugai Pharmaceutical Co’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 11 Wall Street analysts.
How can I buy shares of Chugai Pharmaceutical Co?
To buy shares of DE:CUP, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.